查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1632676

美國製藥隔離器市場：市場規模、佔有率、趨勢分析（按類型和產品）、細分市場預測（2025-2030 年）

U.S. Pharmaceutical Isolators Market Size, Share & Trends Analysis Report By Type (Open Isolator, Closed Isolator), By Product (Positive Pressure, Negative Pressure), And Segment Forecasts, 2025 - 2030
出版日期: | 出版商: Grand View Research | 英文 110 Pages | 商品交期: 2-10個工作天內

價格

美國製藥隔離器市場的成長與趨勢

根據 Grand View Research, Inc. 的最新報告，美國製藥隔離器市場規模預計到 2030 年將達到 2.226 億美元，2025 年至 2030 年的複合年成長率為 6.0%。預計美國製藥業的快速成長及其行業技術的進步將對市場成長產生積極影響。

美國製藥業的成長主要得益於醫藥和生物科學領域的不斷進步。預計對無菌加工的腸外藥物的需求不斷成長，以及該行業的投資不斷增加，將推動美國市場的發展。

製藥隔離器在採用機器人技術、自動化解決方案和工業 4.0 方面代表了無菌處理領域的快速技術進步。將機器人技術納入無球形藥物隔離器可降低人為干預而造成微生物污染和顆粒污染的風險。

該行業正在朝著能源效率和永續性的方向發展。與限制進入屏障系統（RABS）相比，製藥隔離器的能源效率更高。與RABS的30%節能相比，製藥隔離器的節能率最高可達65%，因此對製藥隔離器的需求也隨之增加。

美國製藥隔離器市場：分析概述

  • 密封隔離器適用於有毒物質的製備，因為它可以在關鍵區域無需人工操作，預計 2025 年至 2030 年的複合年成長率為 5.7%。
  • 正壓部分佔 2024 年總收益佔有率的 54.6%。這是因為無菌製程的要求特別嚴格，並且將污染物排除在隔離器之外是首要任務。
  • 公司正在與教育機構以及內部研發機構合作，開發能夠為未來提供永續優勢的流程和技術。
  • 2021 年 2 月，Comecer SpA 與 Illuminate Manufacturing Intelligence 合作，整合以工業 4.0 為基礎的製藥製造解決方案 Illuminate，以取得製造設備的即時更新。

目錄

第1章 分析方法及範圍

第 2 章執行摘要

第3章美國製藥隔離器市場：促進因素、趨勢與範圍

  • 美國製藥隔離器市場前景
  • 產業價值鏈分析
  • 應用概述
  • 平均價格趨勢分析
  • 供需差距分析（2024年）
  • 法律規範
    • 政策和獎勵計劃
    • 標準與合規性
    • 監管影響分析
  • 市場動態
    • 市場促進因素分析
    • 市場限制分析
    • 產業挑戰
  • 波特五力分析
    • 供應商權力
    • 購買者力量
    • 替代威脅
    • 來自新進入者的威脅
    • 競爭對手之間的競爭
  • PESTEL 分析
    • 政治因素
    • 經濟因素
    • 社會因素
    • 技術因素
    • 環境因素
    • 法律因素

第 4 章美國製藥隔離器市場：展望、估計與預測（按類型）

  • 美國製藥隔離器市場：按類型分類的趨勢分析（2024 年和 2030 年）
    • 開放式隔離器
    • 密封隔離器

第 5 章美國製藥隔離器市場：產品展望、估計與預測

  • 美國製藥隔離器市場：按產品進行趨勢分析（2024 年和 2030 年）
    • 正壓
    • 負壓

第6章 競爭格局

  • 主要市場參與企業的最新趨勢和影響分析
  • 供應商概況
    • 公司分類
    • 主要經銷商及通路夥伴名單
    • 潛在客戶/最終用戶列表
  • 競爭態勢
    • 競爭性基準化分析
    • 戰略地圖
    • 熱圖分析
  • 公司簡介/上市公司
    • COMECER SpA
    • LAF Technologies
    • Iso Tech Design
    • Nuaire
    • Getinge AB
    • SKAN AG
    • M. BRAUN INERTGAS-SYSTEME GMBH
    • IMA SpA
    • AZBIL TELSTAR, SLU
    • Syntegon Technologies GmbH
Product Code: GVR-4-68039-540-4

U.S. Pharmaceutical Isolators Market Growth & Trends:

The U.S. pharmaceutical isolators market size is expected to reach USD 222.6 million by 2030, registering a CAGR of 6.0% from 2025 to 2030, according to a new report by Grand View Research, Inc. The rapid growth of the pharmaceutical industry in the U.S. and advancements in technologies used in the industry are anticipated to have a positive impact on market growth.

The growth of the industry in the U.S. is primarily driven by continuous progress in the field of medicines and bioscience. The rising demand for aseptically processed parenteral medicines, along with increased investments in the industry, is anticipated to drive the market in the U.S.

Pharmaceutical isolators are seeing fast-paced technological advancements in aseptic processing in terms of incorporation of robotics and automation solutions and industry 4.0. By integrating robotics within gloveless pharmaceutical isolators, the risk of microbe contamination, as well as particle contamination caused by human intervention is reduced.

The industry is moving toward energy efficiency and sustainability. Pharmaceutical isolators offer higher energy efficiency as compared to the Restricted Access Barrier System (RABS). Energy saving in pharmaceutical isolators can be up to 65% as compared to 30% offered by RABS which is likely to positively improve their demand.

U.S. Pharmaceutical Isolators Market Report Highlights:

  • The closed isolators segment is expected to witness a CAGR of 5.7% from 2025 to 2030 owing to the ability to operate without personnel access to the critical zone, making them suitable for application in the preparation of toxic materials
  • The positive pressure segment accounted for 54.6% of the overall revenue share in 2024, owing to its demand in sterile processes when the process is of particular significance and keeping any contaminants out of the isolator is a priority
  • Companies are collaborating with educational institutions along with their in-house R&D facilities for developing processes and technologies that offer a sustainable advantage in the future
  • In February 2021, Comecer S.p.A partnered with Illuminate Manufacturing Intelligence, to integrate Illuminate, a pharmaceutical production solution based on industry 4.0, to get real-time updates of their manufacturing equipment

Table of Contents

Chapter 1. Methodology and Scope

  • 1.1. Market Segmentation & Scope
  • 1.2. Market Definition
  • 1.3. Information Procurement
    • 1.3.1. Purchased Database
    • 1.3.2. GVR's Internal Database
    • 1.3.3. Secondary Sources & Third-Party Perspectives
    • 1.3.4. Primary Research
  • 1.4. Information Analysis
    • 1.4.1. Data Analysis Models
  • 1.5. Market Formulation & Data Visualization
  • 1.6. Data Validation & Publishing

Chapter 2. Executive Summary

  • 2.1. Market Insights
  • 2.2. Segmental Outlook
  • 2.3. Competitive Outlook

Chapter 3. U.S. Pharmaceutical Isolators Market Variables, Trends & Scope

  • 3.1. U.S. Pharmaceutical Isolators Market Outlook
  • 3.2. Industry Value Chain Analysis
  • 3.3. Application Overview
  • 3.4. Average Price Trend Analysis
  • 3.5. Supply-Demand Gap Analysis, 2024
  • 3.6. Regulatory Framework
    • 3.6.1. Policies and Incentive Plans
    • 3.6.2. Standards and Compliances
    • 3.6.3. Regulatory Impact Analysis
  • 3.7. Market Dynamics
    • 3.7.1. Market Driver Analysis
    • 3.7.2. Market Restraint Analysis
    • 3.7.3. Industry Challenges
  • 3.8. Porter's Five Forces Analysis
    • 3.8.1. Supplier Power
    • 3.8.2. Buyer Power
    • 3.8.3. Substitution Threat
    • 3.8.4. Threat From New Entrant
    • 3.8.5. Competitive Rivalry
  • 3.9. PESTEL Analysis
    • 3.9.1. Political Landscape
    • 3.9.2. Economic Landscape
    • 3.9.3. Social Landscape
    • 3.9.4. Technological Landscape
    • 3.9.5. Environmental Landscape
    • 3.9.6. Legal Landscape

Chapter 4. U.S. Pharmaceutical Isolators Market: Type Outlook Estimates & Forecasts

  • 4.1. U.S. Pharmaceutical Isolators Market: Type Movement Analysis, 2024 & 2030
    • 4.1.1. Open Isolator
      • 4.1.1.1. Market Estimates and Forecast, 2018 - 2030 (USD Million)
    • 4.1.2. Closed Isolator
      • 4.1.2.1. Market Estimates and Forecast, 2018 - 2030 (USD Million)

Chapter 5. U.S. Pharmaceutical Isolators Market: Product Outlook Estimates & Forecasts

  • 5.1. U.S. Pharmaceutical Isolators Market: Product Movement Analysis, 2024 & 2030
    • 5.1.1. Positive Pressure
      • 5.1.1.1. Market Estimates and Forecast, 2018 - 2030 (USD Million)
    • 5.1.2. Negative Pressure
      • 5.1.2.1. Market Estimates and Forecast, 2018 - 2030 (USD Million)

Chapter 6. Competitive Landscape

  • 6.1. Recent Developments & Impact Analysis, By Key Market Participants
  • 6.2. Vendor Landscape
    • 6.2.1. Company Categorization
    • 6.2.2. List Of Key Distributors and Channel Partners
    • 6.2.3. List Of Potential Customers/End Users
  • 6.3. Competitive Dynamics
    • 6.3.1. Competitive Benchmarking
    • 6.3.2. Strategy Mapping
    • 6.3.3. Heat Map Analysis
  • 6.4. Company Profiles/Listing
    • 6.4.1. COMECER S.p.A.
      • 6.4.1.1. Participant's Overview
      • 6.4.1.2. Financial Performance
      • 6.4.1.3. Product Benchmarking
      • 6.4.1.4. Strategic Initiatives
    • 6.4.2. LAF Technologies
      • 6.4.2.1. Participant's Overview
      • 6.4.2.2. Financial Performance
      • 6.4.2.3. Product Benchmarking
      • 6.4.2.4. Strategic Initiatives
    • 6.4.3. Iso Tech Design
      • 6.4.3.1. Participant's Overview
      • 6.4.3.2. Financial Performance
      • 6.4.3.3. Product Benchmarking
      • 6.4.3.4. Strategic Initiatives
    • 6.4.4. Nuaire
      • 6.4.4.1. Participant's Overview
      • 6.4.4.2. Financial Performance
      • 6.4.4.3. Product Benchmarking
      • 6.4.4.4. Strategic Initiatives
    • 6.4.5. Getinge AB
      • 6.4.5.1. Participant's Overview
      • 6.4.5.2. Financial Performance
      • 6.4.5.3. Product Benchmarking
      • 6.4.5.4. Strategic Initiatives
    • 6.4.6. SKAN AG
      • 6.4.6.1. Participant's Overview
      • 6.4.6.2. Financial Performance
      • 6.4.6.3. Product Benchmarking
      • 6.4.6.4. Strategic Initiatives
    • 6.4.7. M. BRAUN INERTGAS-SYSTEME GMBH
      • 6.4.7.1. Participant's Overview
      • 6.4.7.2. Financial Performance
      • 6.4.7.3. Product Benchmarking
      • 6.4.7.4. Strategic Initiatives
    • 6.4.8. I.M.A. SpA
      • 6.4.8.1. Participant's Overview
      • 6.4.8.2. Financial Performance
      • 6.4.8.3. Product Benchmarking
      • 6.4.8.4. Strategic Initiatives
    • 6.4.9. AZBIL TELSTAR, S.L.U.
      • 6.4.9.1. Participant's Overview
      • 6.4.9.2. Financial Performance
      • 6.4.9.3. Product Benchmarking
      • 6.4.9.4. Strategic Initiatives
    • 6.4.10. Syntegon Technologies GmbH
      • 6.4.10.1. Participant's Overview
      • 6.4.10.2. Financial Performance
      • 6.4.10.3. Product Benchmarking
      • 6.4.10.4. Strategic Initiatives

List of Tables

  • Table 1 List of Abbreviations
  • Table 2 U.S. Pharmaceutical Isolators Market Estimates And Forecasts, By Type, 2018 - 2030 (USD Million)
  • Table 3 Open Isolator Market Estimates And Forecasts, 2018 - 2030 (USD Million)
  • Table 4 Closed Isolator Market Estimates And Forecasts, 2018 - 2030 (USD Million)
  • Table 5 U.S. Pharmaceutical Isolators Market Estimates And Forecasts, By Product, 2018 - 2030 (USD Million)
  • Table 6 Positive Pressure Market Estimates And Forecasts, 2018 - 2030 (USD Million)
  • Table 7 Negative Pressure Market Estimates And Forecasts, 2018 - 2030 (USD Million)

List of Figures

  • Fig. 1 Market Segmentation
  • Fig. 2 Information Procurement
  • Fig. 3 Data Analysis Models
  • Fig. 4 Market Formulation and Validation
  • Fig. 5 Market Snapshot
  • Fig. 6 Segmental Outlook- Type and Product
  • Fig. 7 Competitive Outlook
  • Fig. 8 Value Chain Analysis
  • Fig. 9 Market Dynamics
  • Fig. 10 Porter's Analysis
  • Fig. 11 PESTEL analysis
  • Fig. 12 U.S. Pharmaceutical Isolators Market, By Type: Key Takeaways
  • Fig. 13 U.S. Pharmaceutical Isolators Market, By Type: Market Share, 2024 & 2030
  • Fig. 14 Open Isolator Market, 2018 - 2030 (USD Million)
  • Fig. 15 Closed Isolator Market, 2018 - 2030 (USD Million)
  • Fig. 16 U.S. Pharmaceutical Isolators Market, By Product: Key Takeaways
  • Fig. 17 U.S. Pharmaceutical Isolators Market, By Product: Market Share, 2024 & 2030
  • Fig. 18 Positive Pressure Market, 2018 - 2030 (USD Million)
  • Fig. 19 Negative Pressure Market, 2018 - 2030 (USD Million)